Manami Watanabe-Takahashi
Sendai, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Successful treatment of multiple phototherapy-induced cutaneous squamous cell carcinomas with nivolumab monotherapy.
Journal: European journal of dermatology : EJD
Published: August 28, 2026
Clinical utility of comprehensive genomic profiling in 175 Japanese patients with advanced skin malignancies refractory to standard therapies.
Journal: JAAD international
Published: March 09, 2026
Successful Control of Langer hans Cell Sarcoma in a Super-Aged Patient Using Intensity-Modulated Radiotherapy.
Journal: The Journal of dermatology
Published: December 27, 2025
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.
Journal: The Journal of dermatology
Published: August 09, 2025
A Super-Aged Patient with Primary Cutaneous Gamma-Delta T-Cell Lymphoma Treated with Palliative Radiotherapy: A Short-Term Follow-Up Case.
Journal: Case reports in oncology
Published: April 01, 2025
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.
Journal: Experimental dermatology
Published: March 03, 2025
Two cases of advanced melanoma with BRAF L597 mutation: Options for systemic treatment.
Journal: The Journal of dermatology
Published: February 26, 2025
An Evaluation of Prognostic Factors in Cutaneous Squamous Cell Carcinoma: A Single-Center Study of 237 Japanese Cases.
Journal: Journal of clinical medicine
Published: January 09, 2025
Steroid-resistant Vogt-Koyanagi-Harada-like uveitis due to BRAF/MEK inhibitor, successfully treated with adalimumab.
Journal: European journal of dermatology : EJD
Published: August 28, 2024
Decreased interleukin 4 serum levels correlate with plasminogen activator inhibitor-1 inhibitor TM5614 efficacy in patients with malignant melanoma refractory to anti-programmed cell death protein-1 antibodies: post hoc study of the TM5614-MM trial.
Journal: The British journal of dermatology
Published: June 18, 2024
Radiation-induced cutaneous squamous cell carcinoma showing a significant response to pembrolizumab: A case report.
Journal: The Journal of dermatology
Published: January 16, 2024
Showing 1-11 of 11
Last Updated: 09/26/2026